Elicio Therapeutics
Developing novel cancer immunotherapies
- Publicly traded
- Pharma & life sciences
About Elicio Therapeutics
Clinical-stage biotech company developing novel lymph node-targeted immunotherapies to enhance the immune system's cancer-fighting capabilities against aggressive cancers
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- boston, massachusetts, United States
- Revenue
- $14.1M – $112MTamtam estimate
- Website
- elicio.com
Elicio Therapeutics at a glance
Elicio Therapeutics is a company in the Biotechnology Research industry, headquartered in boston, massachusetts, United States.
Elicio Therapeutics has 11–50 employees.
Elicio Therapeutics's revenue is $14.1M – $112M (Tamtam estimate).
Frequently asked questions about Elicio Therapeutics
What is Elicio Therapeutics's revenue?
Tamtam estimates Elicio Therapeutics's annual revenue at $14.1M – $112M.
How many employees does Elicio Therapeutics have?
Elicio Therapeutics has 11–50 employees.
Where is Elicio Therapeutics headquartered?
Elicio Therapeutics is headquartered in boston, massachusetts, United States.
Selling to companies like Elicio Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies